Kennedy R Lees

发表

Comparison of stratification and adaptive methods for treatment allocation in an acute stroke clinical trial.

Christopher J Weir, K. Lees, C. Weir, 2004, Statistics in medicine.

Results of the MRI substudy of the intravenous magnesium efficacy in stroke trial.

Christopher J Weir, Jeffry R Alger, Jeffrey L Saver, 2009, Stroke.

A multicentre observational study of presentation and early assessment of acute stroke

Lalit Kalra, L. Kalra, K. Lees, 2002, BMJ : British Medical Journal.

Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study

Werner Hacke, Niaz Ahmed, Nils Wahlgren, 2007, The Lancet.

The past is the future: innovative designs in acute stroke therapy trials.

Michael Krams, Donald A Berry, Kennedy R Lees, 2005, Stroke.

Paroxysmal atrial fibrillation after ischemic stroke: how should we hunt for it?

K. Lees, A. Abdul-Rahim, Kennedy R Lees, 2013, Expert review of cardiovascular therapy.

UK-279,276, a Neutrophil Inhibitory Glycoprotein, in Acute Stroke: Tolerability and Pharmacokinetics

Michael Krams, Hans-Christoph Diener, H. Diener, 2003, Stroke.

Thrombolysis with alteplase 3–4·5 h after acute ischaemic stroke (SITS-ISTR): an observational study

Keith Muir, Werner Hacke, Niaz Ahmed, 2008, The Lancet.

Evidence-based stroke r-ehabilitation: an expanded guidance document from the european stroke organisation (ESO) guidelines for management of ischaemic stroke and transient ischaemic attack 2008.

Marion F Walker, Stefano Paolucci, Terence J Quinn, 2009, Journal of rehabilitation medicine.

On the origin of cerebrovascular microemboli associated with prosthetic heart valves.

Tom G Mackay, K. Lees, T. Mackay, 1995, Neurological research.

Central adjudication of serious adverse events did not affect trial’s safety results: Data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial

Rónán Collins, Alan A Montgomery, John Gommans, 2018, PloS one.

Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial

John Whitehead, Antonio Carolei, Hans-Christoph Diener, 2000, The Lancet.

Improving Trial Power Through Use of Prognosis-Adjusted End Points

Christopher J Weir, K. Lees, C. Weir, 2005, Stroke.

Seven-Day NIHSS Is a Sensitive Outcome Measure for Exploratory Clinical Trials in Acute Stroke: Evidence From the Virtual International Stroke Trials Archive

K. Lees, Kennedy R Lees, R. Fulton, 2012, Stroke.

Will Delays in Treatment Jeopardize the Population Benefit From Extending the Time Window for Stroke Thrombolysis?

Martin Pitt, Thomas Monks, David Worthington, 2012, Stroke.

Informal carers' experience of caring for stroke survivors.

Peter Langhorne, Maggie Lawrence, P. Langhorne, 2004, Journal of advanced nursing.

Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): An Adaptive Dose-Response Study of UK-279,276 in Acute Ischemic Stroke

Andrew P Grieve, Michael Krams, Werner Hacke, 2003, Stroke.

Design and analysis of phase III trials with ordered outcome scales: the concept of the sliding dichotomy.

Barbara Gregson, Sung C. Choi, Christopher J Weir, 2005, Journal of neurotrauma.

Comparison of the National Institutes of Health Stroke Scale With Disability Outcome Measures in Acute Stroke Trials

Christopher J Weir, K. Lees, C. Weir, 2005, Stroke.

Exploring the Reliability of the Modified Rankin Scale

Terence J Quinn, M. Walters, J. Dawson, 2009, Stroke.

Robotic Measurement of Arm Movements After Stroke Establishes Biomarkers of Motor Recovery

Hermano I Krebs, Michael Krams, Laura Dipietro, 2014, Stroke.

Does neuroprotection improve stroke outcome?

K. Lees, Kennedy R Lees, 1998, The Lancet.

White-coat hypertension as a cause of cardiovascular dysfunction

J. Reid, K. Lees, J. Curzio, 1996, The Lancet.

Endovascular stent thrombectomy: the new standard of care for large vessel ischaemic stroke

Michael D Hill, Pooja Khatri, Mayank Goyal, 2015, The Lancet Neurology.

Implementation and outcome of thrombolysis with alteplase 3–4·5 h after an acute stroke: an updated analysis from SITS-ISTR

Mark Parsons, Niaz Ahmed, Robert Mikulik, 2010, The Lancet Neurology.

Factors Associated With Intracerebral Hemorrhage After Thrombolytic Therapy for Ischemic Stroke: Pooled Analysis of Placebo Data From the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials

Scott E Kasner, D. Tanné, A. Demchuk, 2009, Stroke.

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

Gregory W Albers, Werner Hacke, Erich Bluhmki, 2010, The Lancet.

Delayed detection of atrial fibrillation after ischemic stroke.

Hooman Kamel, S Claiborne Johnston, H. Kamel, 2009, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

NXY-059 for the treatment of acute ischemic stroke.

Hans-Christoph Diener, J. Grotta, H. Diener, 2007, The New England journal of medicine.